Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis-Reference-Cited by-同舟云学术

Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis

Published:2015-11-25 Issue:1 Volume:77 Page:205-209
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Arbitrio Mariamena,Di Martino Maria Teresa,Barbieri Vito,Agapito Giuseppe,Guzzi Pietro Hiram,Botta Cirino,Iuliano Eleonora,Scionti Francesca,Altomare Emanuela,Codispoti Stefania,Conforti Serafino,Cannataro Mario,Tassone Pierfrancesco,Tagliaferri Pierosandro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2916-3.pdf

Reference19 articles.

1. Rusch V, Mendelsohn J, Dmitrovsky E (1996) The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev 7(2):133–141

2. Ling J, Johnson KA, Miao Z, Rakhit A, Pantze MP, Hamilton M, Lum BL, Prakash C (2006) Metabolism and excretion of erlotinib, a small molecule inhibitor of epidermal growth factor receptor tyrosine kinase, in healthy male volunteers. Drug Metab Dispos Biol Fate Chem 34(3):420–426. doi: 10.1124/dmd.105.007765

3. Rudin CM, Liu W, Desai A, Karrison T, Jiang X, Janisch L, Das S, Ramirez J, Poonkuzhali B, Schuetz E, Fackenthal DL, Chen P, Armstrong DK, Brahmer JR, Fleming GF, Vokes EE, Carducci MA, Ratain MJ (2008) Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. J Clin Oncol 26(7):1119–1127. doi: 10.1200/JCO.2007.13.1128

4. Holcmann M, Sibilia M (2015) Mechanisms underlying skin disorders induced by EGFR inhibitors. Mol Cell Oncol 2(4). doi: 10.1080/23723556.2015.1004969

5. Perez-Soler R (2006) Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancer. Clin Lung Cancer 8(Suppl 1):S7–S14

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Pathways;Reference Module in Life Sciences;2024

2. SEDEG: An automatic method for preprocessing and selection of seed genes from gene expression data;Informatics in Medicine Unlocked;2024

3. What is precision medicine in oncology?;Liquid Biopsy;2023

4. Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients;Journal of Clinical Medicine;2022-10-21

5. A Python Clustering Analysis Protocol of Genes Expression Data Sets;Genes;2022-10-12